Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice

Psychopharmacology

Volumn 145, Issue 3, 1999, Pages 237-250

  O'Neill, Michael F ^a   Shaw, Gillian ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Amphetamine; Antipsychotic; Cocaine; Locomotion; MK 801; Raclopride; SCH23390

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; CLOZAPINE; COCAINE; DIZOCILPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; RACLOPRIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; BENZAZEPINES; COCAINE; DIZOCILPINE MALEATE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; LOCOMOTION; MICE; RECEPTORS, DOPAMINE D1;

EID: 0032784823     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051055     Document Type: Article

References (37)

1. 3H]SCH23390 binding to dopamine receptors in vivo in mouse brain. Eur J Pharmacol 146:113-120
2. Brauer LH, De Wit H (1997) High dose of pimozide does not block amphetamine-induced euphoria in normal volunteers. Pharmacol Biochem Behav 56:265-272
3. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87-96
4. 2 receptor antagonists differentially affect cocaine-induced locomotor hyperactivity in the mouse. Psychopharmacology 105:335-339
5. 2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulation of monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse-implications for psychosis. J Neural Transm [Gen Sect] 100:225-237
6. Carlsson M, Carlsson A (1989) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75:221-226
7. 2 dopamine receptor classification and its functional implications. Synapse 1:347-388
8. Clineschmidt BV, Martin GE, Bunting PR, Papp AL (1982) Central sympathomimetic activity of (+)-5-methol-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Dev Res 2:135-145
9. Corbett R, Camacho F, Woods AT, Kerman LL, Fishkin RJ, Brooks K, Dunn RW (1995) Antipsychotic agents antagonize non-competitive N-methyl D-aspartate antagonist-induced behaviors. Psychopharmacology 120:67-74
10. 1-like" dopamine receptor agonists. Psychopharmacology 58:551-558
11. Freed WJ, Bing LA, Wyatt RJ (1984) Effects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice. Neuropharmacology 23:175-181
12. Gleason SD, Shannon HE (1997) Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology 129:79-84
13. Hiramatsu M, Cho AK, Nabeshima T (1989) Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur J Pharmacol 166:359-366
14. Hitri A, O'Connor DA, Cohen JM, Keuler DJ, Deutsch SI (1993) Differentiation between MK-801 and apomorphine-induced stereotyped behaviors in mice. Clin Neuropharmacol 16:220-236
15. Iwamoto ET (1984) An assessment of the spontaneous activity of rats administered morphine, phencyclidine, or nicotine using automated and observational methods. Psychopharmacology 84:374-382
16. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308
17. 1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients. Psychopharmacology 121:309-316
18. 2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice. Behav Brain Res 70:145-151
19. Liljequist S, Ossowska K. Grabowska-Anden M, Anden N-E, (1991) Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur J Pharmacol 195:55-61
20. Lillrank SM, O'Connor WT, Oja SS, Ungerstedt U (1994) Systemic phencyclidine administration is associated with increased dopamine, GABA, and 5HIAA levels in the dorsolateral striatum of conscious rats: an in vivo microdialysis study. J Neural Transm [Gen Sect] 95:145-155
21. Martin P, Svensson A, Carlsson A, Carlsson ML (1994) On the roles of dopamine D-1 vs. D-2 receptors for the hyperactivity response elicited by MK-801. J Neural Transm [Gen Sect] 95:113-121
22. Molloy AG, Waddington JL (1987) Assessment of grooming and other behavioural responses to the D-1 receptor agonist SK&F 38393 and its R-and S-enantiomers in the intact adult rat. Psychopharmacology 92:164-168
23. 1 dopamine receptor. Neuropharmacology 28:401-405
24. 2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions. Psychopharmacology 90:287-294
25. 2 receptor antagonists on hyperactivity, c-fos and hsp-70 induced by dizocilpine (MK-801) in mice. J Psychopharmacol 11S:A79
26. 2 receptor blockade on MK-801-induced hyperactivity in rats. Psychopharmacology 111:427-434
27. Rebec GV, Bashore TR (1984) Critical issues in assessing the behavioral effects of amphetamine. Neurosci Biobehav Rev 8:153-159
28. Segal DS, Schuckit MA (1983) Animal models of stimulant-induced psychosis. In: Creese I (ed) Stimulants: neurochemical, behavioural and clinical perspectives. Raven Press, New York, pp 131-167
29. 2, receptors. Psychopharmacology 123:303-306
30. 1 agonists A-86929 and ABT-431. Eur J Pharmacol 317:183-190
31. Svensson A, Pileblad E, Carlsson M (1991) A comparison between the non-competitive NMDA antagonist (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor stimulatory properties in mice. J Neural Transm [Gen Sect] 85:117-129
32. 2 dopamine systems in the behavioral effects of cocaine in rats. Pharmacol Biochem Behav 52:737-741
33. Verma A, Kulkarni S (1992) Modulation of MK-801 response by dopaminergic agents in mice. Psychopharmacology 107:431-436
34. Waddington J, Daly S, Downes R, Deveney A, McCauley P, O'Boyle K (1995) Behavioural pharmacology of "D-1-like" dopamine receptors: further subtyping, new pharmacological probes and interactions with "D-2-like" receptors. Prog Neuropsychopharmacol Biol Psychiatry 19:811-831
35. Willins DL, Narayanan S, Wallace LJ, Uretsky NJ (1993) The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801. Pharmacol Biochem Behav 46:881-887
36. Witkin JM, Nichols DE, Terry P, Katz JL (1991) Behavioural effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257:706-713
37. Yan Q-S, Reith MEA, Jobe P, Daily JW (1997) Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine in the nucleus accumbens as measured by microdialysis in freely moving rats. Eur J Pharmacol 765: 149-158